Conference Program
Pre-registration and payment required
Chief Scientist, Asana Bio Group Ltd., Israel
Co-Founder & CTO, Seach Medical Cannabis Group, Israel
Founder & CSO, Abagune Research, Vitoria-Gasteiz, Spain
09:30 - 09:35
Mr. Yossi Bornstein
Conference Co-Chair; Founder and Director, Cann10, Israel
09:35- 09:45
Dr. Raquel Peyraube
Conference Co-Chair, CannX Lisbon, Director of Public Policy and Health, Plena Global, Member of the IACM EC (International Association for Cannabinoid Medicines), Uruguay
09:45-09:50
Dr Ana Paula Martins
President of the Portuguese Pharmaceutical Society, Portugal
09:50-09:55
Miguel Guimarães
President of the Portuguese Medical Society, Portugal
09:55-10:00
Dr Rui Ivo
President of Infarmed I.P., Portugal
MEDICAL GRADE CANNABIS: DEFINITION AND CONCEPTS
Chair: Prof. Lumir Hanus, Israel
Dr. Raquel Peyraube
Director of Public Policy and Health, Plena Global, Member of the IACM EC (International Association for Cannabinoid Medicines), Uruguay
Auditoruim I
PARALLEL SESSIONS
.
Innovations in Science and Medicine
Auditoruim II
11:00 – 12:00
INTEGRATIVE TREATMENTS WITH CANNABINOIDS FOR NEURO-PSYCHIATRIC DISORDERS
Chair: Prof. Kirsten Muller Vahl
Hannover Medical School, Clinic of Psychiatry, Social Psychiatry and Psychotherapy, Germany
11:00 – 11:20
PRECLINICAL DEVELOPMENT OF A CANNABINOID-BASED THERAPY AGAINST NEURODEGENERATIVE DISORDERS
Prof. Javier Fernandez-Ruiz
Complutense University of Madrid, Spain
11:20 – 11:40
TREATING AUTISM WITH MEDICAL CANNABIS
Dr. Orit Stolar
Pediatric Neurologist, Assaf Harofeh Medical Center, Israel
11:40 – 12:00
TOURETTE SYNDROME
Prof. Kirsten Müller-Vahl
Hannover Medical School, Clinic of Psychiatry, Social Psychiatry and Psychotherapy, Germany
Auditoruim III
11:00 – 12:00
NEW AND INNOVATIVE DELIVERY METHODS
Industry session not included in the main event CME/CPD credit
Click HERE for the session content
PARALLEL SESSIONS
.
Innovations in Science and Medicine
Auditoruim II
12:00 – 13:20
OPENING THE GATES TO NEW CLINICAL RESEARCH AND INDICATIONS
Chair: Prof. Saoirse O’Sullivan
Associate Professor, Faculty of Medicine & Health Sciences, University of Nottingham, UK
12:00 – 12:20
POTENTIAL CANNABINOIDS TREATMENTS FOR SKIN DISEASES
Dr. Tamas Biro
Department of Immunology, University of Debrecen, Hungary
12:20 – 12:40
CARDIOVASCULAR CONDITIONS
Prof. Saoirse O’Sullivan
Associate Professor, Faculty of Medicine & Health Sciences, University of Nottingham, UK
12:40 – 13:00
DIABETES
Dr. Tony Jourdan
Chargé de Recherche, INSERM, France
13:00 – 13:20
Q&A
Auditoruim III
12:00 – 13:20
ADVANCED GROWING TECHNOLOGIES
Industry session not included in the main event CME/CPD credit
Click HERE for the session content
Auditoruim I
THE CANNABINOID SYSTEM: WHERE DO WE STAND TODAY?
Prof. Raphael Mechoulam
Institute for Drug Research, The Hebrew University of Jerusalem, Israel
PARALLEL SESSIONS
.
Innovations in Science and Medicine
Auditoruim II
14:55 – 15:55
THE ENDOCANNABINOID SYSTEM AND PROMISING FINDINGS WITH CLINICAL IMPORTANCE
Chair: Dr. Guillermo Moreno Sanz
14:55 – 15:15
THE ENDOCANNABINOID SYSTEM IN HUMAN PHYSIOLOGY
Dr. Guillermo Moreno Sanz
Founder & CSO, Abagune Research, Vitoria-Gasteiz, Spain
15:15 – 15:35
EFFECTS OF TERPENES IN THE ENDOCANNABINOID SYSTEM AND EXPECTED INTERACTIONS WITH CANNABINOIDS
Prof. Lumír Hanus
Chief Scientist, Asana Bio Group Ltd., Israel
15:35 – 15:55
ENDOCANNABINOID SIGNALING IN THE BRAIN: FROM BASIC MECHANISMS TO PSYCHIATRIC DISEASES
Prof. Mauro Maccarrone
Professor and Chair of Biochemistry and Molecular Biology, Department of Medicine, Campus Bio-Medico University of Rome, Italy
Auditoruim III
14:55 – 15:55
PATIENTS VS. PROFIT: THE INTERACTION OF THE INDUSTRY WITH THE CLINIC
Industry session not included in the main event CME/CPD credit
Click HERE for the session content
LESSONS FROM REAL-WORLD CASE STUDIES
Industry session not included in the main event CME/CPD credit
PARALLEL SESSIONS
.
Innovations in Science and Medicine
Auditoruim II
09:30 – 10:30
CANNABIS AND CANNABINOIDS IN CANCER CARE AND PERSONALIZED TREATMENT
Chair: Yuval Zolotov
Ph.D, Network and Partnership Coordinator, International Association for Cannabinoid Medicine, Israel
09:30 – 09:50
MECHANISM OF ACTION OF CANNABINOIDS IN CANCER
Dr. Guillermo Velasco
Department of Biochemistry and Molecular Biology, Complutense University of Madrid, Spain
09:50 – 10:10
MEDICAL CANNABIS USE AMONG CANCER SURVIVORS
Dr. Yuval Zolotov
Ph.D, Network and Partnership Coordinator, International Association for Cannabinoid Medicine, Israel
10:10 – 10:30
TUNING THE ENDOCANNABINOID SYSTEM: WHEN TREATMENT MATCHES THE PATIENT
Dr Fabricio Pamplona
Proprium, Portugal
Auditoruim III
09:30 – 10:30
MEDICAL CANNABIS OPERATIONS: FROM THEORY TO PRACTICE
Industry session not included in the main event CME/CPD credit
Click HERE for the session content
Auditoruim I
PARALLEL SESSIONS
Innovations in Science and Medicine
Auditoruim II
11:00 – 11:30
PHARMACOLOGICAL ACTIONS AND POTENTIAL NOVEL THERAPEUTIC USES OF CANNABINOIDS
Prof. Roger Pertwee
Institute of Medical Sciences, University of Aberdeen, UK
Auditoruim II
11:30 – 12:00
THC AND CBD INTERACTIONS WITH SERIOUS RISKS FOR HUMAN HEALTH
Prof. Marta Vázquez
Faculty of Chemistry, Universidad de la República Oriental del Uruguay, Uruguay
Auditoruim III
11:00 – 12:00
SPECIAL FOCUS ON PORTUGAL
Industry session not included in the main event CME/CPD credit
Click HERE for the session content
Moderator: Dr. Raquel Peyraube, Director of Public Policy and Health, Plena Global, Member of the IACM EC (International Association for Cannabinoid Medicines), Uruguay
WHERE IS THE UN GOING?
Pien Metaal
Transnational Institute, The Netherlands
CHALLENGES FOR PATIENTS AND THE INDUSTRY WITHIN COMPLEX REGULATORY FRAMEWORKS
Dr. Catherine Jacobson
VP, Regulatory & Medical Affairs, Tilray, Canada
CANNABIS REGULATIONS: A PUBLIC HEALTH PERSPECTIVE
Dr. Andres Lopez Velasco
Former Director of the National Narcotics Office, Ministry of Health and Social Protection, Colombia
Brendan Hughes
European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), Portugal
Auditoruim I
Industry session not included in the main event CME/CPD credit
PARALLEL SESSIONS
.
Innovations in Science and Medicine
Auditoruim II
14:30 – 15:00
IMPORTANT PARTNERS – COMPOUND MAPPING
Dr. Gil Lewitus
Laboratory of Cancer Biology and Cannabinoid Research, Technion, Israel Institute of Technology, Israel
Auditoruim II
15:00 – 15:30
ARE EXTRACTION METHODS DETERMINANTS FOR THE QUALITY OF CANNABIS-BASED MEDICINES?
Dr. Xavier Nadal
Director of Extraction Department, Plena Global, Spain
Auditoruim III
14:30 – 15:30
IDEAL EUROPEAN LOCATIONS FOR MEDICAL CANNABIS OPERATIONS
Industry session not included in the main event CME/CPD credit
Click HERE for the session content
Auditoruim I
ARE CANNABIS & CANNABINOIDS A RISK OR A BENEFIT FOR MENTAL HEALTH?
Chair: Dr Raquel Peyraube, Uruguay
Dr. Francisco Guimaraes
Department of Pharmacology, University of São Paulo, Brazil
Yael Meir, COO, Cann10. Israel
Dr. Raquel Peyraube
Director of Public Policy and Health, Plena Global, Member of the IACM EC (International Association for Cannabinoid Medicines), Uruguay